Why Biden in New Orleans Still Matters for the Future of Cancer Research

Why Biden in New Orleans Still Matters for the Future of Cancer Research

New Orleans has a way of making everything feel a bit more intense. The heat, the history, the music—it all sticks to you. When President Joe Biden and First Lady Jill Biden touched down in the Big Easy in mid-August 2024, the atmosphere wasn't just about politics. It was personal.

Honestly, if you've followed Biden’s career, you know he doesn't just "do" policy when it comes to healthcare. He lives it. The visit to Tulane University was a major moment for the Biden Cancer Moonshot initiative, and it brought some serious cash to the table—$150 million in total federal awards, with a massive chunk landing right in the heart of Uptown New Orleans.

What Actually Happened at Tulane?

Basically, the President wasn't just there to shake hands. He was there to announce that Tulane University is receiving up to $22.9 million to develop something that sounds like sci-fi but is actually becoming reality.

The project is called MAGIC-SCAN. It stands for Machine-learning Assisted Gigantic Image Cancer margin SCANner. Yeah, it's a mouthful. But here’s the gist: when a surgeon is removing a tumor, they’re often flying partially blind. They cut out what they see, but tiny, microscopic cancer cells can stay behind.

Usually, you’d have to wait days for a lab to tell you if they missed a spot. By then, the patient is already sewn up and recovering. With the technology being built at Tulane by researchers like Dr. Quincy Brown and Brian Summa, surgeons could scan the tissue in minutes right there in the OR.

Why the New Orleans Stop was Different

You might wonder why New Orleans? Why not a massive lab in Boston or San Francisco?

💡 You might also like: Passive Resistance Explained: Why It Is Way More Than Just Standing Still

The truth is, Louisiana has some of the highest cancer mortality rates in the country. It’s a place where access to care is often a nightmare. Dr. Joe Ramos, the CEO of the Louisiana Cancer Research Center, has been vocal about this. It doesn’t matter if you have a miracle drug if the person living in a rural parish can’t get to the clinic.

Biden's visit signaled a shift. It wasn't just about the "moonshot" of finding a cure; it was about the "precision" of making sure the first surgery is the only surgery.

He stayed for a while. He watched demonstrations. He talked about his son, Beau. You could tell he wasn't reading off a teleprompter for half of it. He mentioned that cancer is "one of the most devastating words anyone can hear." And in a room full of scientists at the Goldring-Woldenberg Business Complex, that sentiment hit home.

The $150 Million Breakdown

While Tulane got the spotlight, they weren't the only ones. The ARPA-H (Advanced Research Projects Agency for Health) spread that $150 million across eight different teams. We're talking about:

  • Johns Hopkins University
  • Rice University
  • University of Washington
  • Dartmouth College
  • UC San Francisco

This wasn't just a "feel-good" trip. It was a strategic deployment of federal resources aimed at a very specific problem: surgical margins.

📖 Related: What Really Happened With the Women's Orchestra of Auschwitz

What People Get Wrong About the Moonshot

A lot of folks think the Cancer Moonshot is just a big pot of money for "research." That's kinda true, but it’s more specific than that. The 2024 visit highlighted a goal to cut cancer deaths by 50% over the next 25 years.

That’s a tall order.

But Biden in New Orleans emphasized that the bottleneck isn't always the science; it’s the technology in the room. If MAGIC-SCAN works, it reduces the need for "re-operation." If you've ever known someone who had to go back under the knife because the margins weren't "clear," you know how soul-crushing that is.

The Later, More Somber Visit

It's worth noting that Biden returned to New Orleans in early January 2025 under much darker circumstances. He visited Bourbon Street to lay flowers for the 14 victims of the horrific New Year’s Day truck attack.

That visit was about grief. It was about a city that had been rocked by a "lone wolf" terror attack. He sat in St. Louis Cathedral, listened to a jazz version of "Amazing Grace," and told the families that "the memory of your loved one will make you smile before it makes you cry."

👉 See also: How Much Did Trump Add to the National Debt Explained (Simply)

It showed the dual nature of his relationship with the city—one visit for hope and the future of science, another for the heavy, communal burden of loss.

What This Means for You

If you’re a resident of Louisiana or just someone following medical tech, these visits aren't just headlines. They are indicators of where the money is flowing.

Next Steps for Patients and Families:

  • Check Clinical Trials: With the $22.9 million infusion, Tulane is going to be a hub for clinical validation. If you or a loved one are facing surgery, ask your oncologist about ARPA-H funded trials.
  • Screening Matters: The Moonshot isn't just about surgery; it’s about early detection. Louisiana has expanded access to screenings—don't let the "pandemic lag" keep you from getting checked.
  • Watch the Tech: Keep an eye on Instapath Inc., the Tulane spin-out company mentioned during the visit. They are the ones actually turning this lab tech into something your local hospital can buy.

New Orleans isn't just a place for parades. It’s becoming a literal battlefield in the fight against cancer. Biden's visits here cemented that. The work happening Uptown might just be the reason someone you love doesn't have to go back for a second surgery five years from now.